Project Details
Description
A phase 2, two-part study to assess the safety, antiviral biomarker responses, and efficacy of inhaled SNG001 for the treatment of patients with a confirmed respiratory virus infection undergoing invasive mechanical ventilation
| Status | Active |
|---|---|
| Effective start/end date | 2/11/25 → 2/10/36 |
Funding
- SYNAIRGEN RESEARCH LTD
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.